It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

As infection rates of illnesses carried by mosquitoes increase, companies and researchers are racing to develop effective ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Health Canada's approval is based on data from the Phase 3 clinical trial ConquerRSV, a global study conducted in approximately 37,000 adults aged 60 years and older in 22 countries. No serious safety ...

In the U.S., wastewater surveillance for public health became vital during the COVID-19 pandemic, when the U.S. Centers for Disease Control and ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

Canada reports its first presumptive human H5 bird flu case ... marking the first mRNA-based authorized vaccine for ...